Wealthspire Advisors (Maryland)’s Enanta Pharmaceuticals ENTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q2
Sell
-44
Closed -$4K 926
2019
Q1
$4K Hold
44
﹤0.01% 1893
2018
Q4
$3K Buy
44
+14
+47% +$955 ﹤0.01% 1932
2018
Q3
$3K Buy
30
+28
+1,400% +$2.8K ﹤0.01% 2015
2018
Q2
$0 Hold
2
﹤0.01% 2469
2018
Q1
$0 Hold
2
﹤0.01% 2529
2017
Q4
$0 Hold
2
﹤0.01% 2479
2017
Q3
$0 Buy
+2
New ﹤0.01% 2309